PubMed Health⌕ Search

PubMed · 8844208

Mutation pattern in clinically asymptomatic coagulation factor VII deficiency.

Abstract

A total of 122 subjects, referred after presurgery screening or checkup for prolonged prothrombin time, were characterized for the presence of coagulation factor VII deficiency. Fourteen subjects carried a partial and asymptomatic deficiency, and in half of them dysfunctional molecules were detected in plasma. In nine subjects we found five missense mutations differing from those previously found in factor VII deficient patients. The others were homozygous for a common polymorphism (R353Q) that affects factor VII levels. A new codon dimorphism (A330) was also found in exon 8. Four mutations (R223W, M298I, R304Q, and R353Q) located at FVII-specific residues point out protein regions that are important for coagulation factor evolution, and two mutations (G342E and E265K) affect generic or partially generic residues. The newly reported mutations were combined with those we previously found, totalling 17 independent mutations responsible for FVII deficiency in 27 Italian pedigrees. We observed several similarities with the mutation pattern determined in factor IX, which include a high percentage of transitions at CpG doublets, the presence of hot spot sites affected by multiple substitutions, and of several topologically equivalent mutations.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

F Bernardi, G Castaman, M Pinotti, P Ferraresi, M G Di Iasio, B Lunghi, F Rodeghiero, G Marchetti. 1996. Mutation pattern in clinically asymptomatic coagulation factor VII deficiency.. https://doi.org/10.1002/(sici)1098-1004(1996)8%3A2%3C108%3A%3Aaid-humu2%3E3.0.co%3B2-7

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Acquired isolated factor VII deficiency and bronchogenic carcinoma. A case report].

An acquired factor VII deficiency was identified in a 63-year-old man with bronchogenic carcinoma. Initial studies indicated a normal activated partial thromboplastin time and a prolonged prothrombin time. The factor VII level was 6%. No evidence of a factor VII inhibitor or inactivator was demonstrable. However, on account of the initial normal laboratory test of emostases, the partial correction of the prothrombin time with 50% normal plasma in vitro and the family history, the congenital deficiency in factor VII was ruled out. Whatever the mechanism involved, this factor VII deficiency was related to malignancy.

Factor VII Deficiency↗